Results 221 to 230 of about 80,637 (252)

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, Volume 20, Issue 9, Page 2203-2219, September 2026.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Pharmacovigilance analysis of immune checkpoint inhibitor-associated optic nerve toxicity based on the FAERS database. [PDF]

Front Pharmacol
Bao H, Lin L, Huan W, Bao H, Su H, Luo X, Deng C, Hu J, Cao X, Wu X.   +9 more
europepmc   +1 more source

Immune Checkpoint Inhibitor–Related Myositis and Associated Triad Overlap Syndrome

Arthritis Care &Research, Volume 78, Issue 9, Page 1123-1129, September 2026.
Objective Immune checkpoint inhibitor (ICI) myositis is a rare but a highly morbid condition, particularly with the ICI myositis triad syndrome of myositis, myocarditis, and myasthenia gravis. We report the clinical characteristics of ICI myositis and all‐cause mortality in these patients.
Selene Rubino, Grant W. Cannon, Brian C. Sauer, Jorge Rojas, Gregory J. Stoddard, Gary A. Kunkel, Jessica A. Walsh, Bryant R. England, Joshua F. Baker, Tawnie J. Braaten   +9 more
wiley   +1 more source

A Case of Nivolumab-Induced Bullous Pemphigoid-Successfully Treated with Rituximab. [PDF]

J Community Hosp Intern Med Perspect
Amin R, Ranpura N, Hatic H.
europepmc   +1 more source

Biosimilar Nivolumab-Based Combination Therapy in Advanced Oral Cavity Squamous Cell Carcinoma: A Real-World Case Series of Five Patients. [PDF]

Cureus
Meedimale S, Panda SS, Thummar V, Bhavsar H.   +3 more
europepmc   +1 more source

Ocular adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FAERS database. [PDF]

Front Pharmacol
Liu X, Ji A.
europepmc   +1 more source

Clinical benefits, tolerability, and risk factors of adjuvant nivolumab for muscle-invasive bladder cancer. [PDF]

Transl Androl Urol
Watanabe H, Ishikawa G, Watanabe S, Watanabe S, Watanabe K, Matsushita Y, Tamura K, Motoyama D, Inamoto T.   +8 more
europepmc   +1 more source

Real-World Treatment Patterns in Advanced Cutaneous Melanoma in the USA. [PDF]

Target Oncol
Block MS, Stenzel AE, Marcotte R, Wallace KL.   +3 more
europepmc   +1 more source